ONC:NASDAQ
BeOne Medicines AG
270,10 US$
arrow_downward
-3,51%(-9,83) 1K
269,00 US$
arrow_downward
-0,41% (-1,10)bedtimeYopilgandan keyin
Savdolar yopilgan: 5-iyn, 16:00:00 (GMT-4) · USD
search
Barcha belgilar
1K
5K
1O
6O
YBB
1Y
5Y
MAKS
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoONC tikeri uchun statistika yaratilmoqda...
Ochish
275,18 US$
Yuqori
275,18 US$
Past
269,00 US$
Bozor kapitali
33,42 mlrd
Oʻrtacha hajm
229,79 ming
Hajmi
325,96 ming
52 haftalik eng yuqori
385,22 US$
52 haftalik eng past
239,25 US$
Beta
0,49
Muomaladagi aksiyalar
118,57 mln
Xodimlar soni
12 ming
Ochish
275,18 US$
Yuqori
275,18 US$
Past
269,00 US$
Bozor kapitali
33,42 mlrd
Oʻrtacha hajm
229,79 ming
Hajmi
325,96 ming
52 haftalik eng yuqori
385,22 US$
52 haftalik eng past
239,25 US$
Beta
0,49
Muomaladagi aksiyalar
118,57 mln
Xodimlar soni
12 ming
Tahlilchilar prognozi
Analitik reytinglar
Oxirgi 3 oyda ONC aksiyalari boʻyicha reyting bergan 13 tahlilchi xulosasiga koʻra
Kuchli xarid
Sotib olish
12
Ushlab qolish
1
Sotish
0
12 oylik prognoz
Oxirgi 3 oyda ONC uchun 12 oylik narx maqsadlarini taklif qilgan 13 Wall Street tahlilchisi xulosasiga koʻra
Eng yuqori
Joriy 270,10 US$
436,00 US$ (+61,42%)
O‘rtacha
393,49 US$ (+45,68%)
Eng past
333,00 US$ (+23,29%)
Yangiliklar
Internetdagi manbalardan
TipRanks
·
3 kun oldin
Why BeOne Medicines Stock Is Sliding Today
Profil
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
Founded in 2010 by chief executive officer John V. Oyler and Xiaodong Wang, the company is headquartered in Cambridge, Massachusetts and has locations on six continents, in over 45 countries. BeOne has a large presence in the Chinese market.
BeOne Medicines has developed several medicines, including tislelizumab, a checkpoint inhibitor, and zanubrutinib, a Bruton's tyrosine kinase inhibitor. On 14 November 2024 the company announced its intention to rebrand as BeOne Medicines. BeOne changed its stock ticker to ONC in January 2025 and redomiciled to Basel, Switzerland in May 2025. Wikipedia
BeOne Medicines AG haqida
CEOJohn Vincent Oyler | John Vincent Oyler
Xodimlar soni12 ming
Asos solingan28-okt, 2010
Bosh ofislar-
Sektor-
Veb-saytbeonemedicines.com
AI kontentda xatolar boʻlishi mumkin. Batafsil